ES8608490A1 - Procedimiento de obtencion de una preparacion farmaceutica en forma de liberacion lenta y que comprende pinacidil (n'-ciano-n-4-piridil-n'-1, 2, 2-trimetil-propilguanidina), opcionalmente junto con otros componentes - Google Patents

Procedimiento de obtencion de una preparacion farmaceutica en forma de liberacion lenta y que comprende pinacidil (n'-ciano-n-4-piridil-n'-1, 2, 2-trimetil-propilguanidina), opcionalmente junto con otros componentes

Info

Publication number
ES8608490A1
ES8608490A1 ES529660A ES529660A ES8608490A1 ES 8608490 A1 ES8608490 A1 ES 8608490A1 ES 529660 A ES529660 A ES 529660A ES 529660 A ES529660 A ES 529660A ES 8608490 A1 ES8608490 A1 ES 8608490A1
Authority
ES
Spain
Prior art keywords
pinacidil
balls
slow release
coating
piridil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES529660A
Other languages
English (en)
Spanish (es)
Other versions
ES529660A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of ES8608490A1 publication Critical patent/ES8608490A1/es
Publication of ES529660A0 publication Critical patent/ES529660A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES529660A 1983-02-11 1984-02-10 Procedimiento de obtencion de una preparacion farmaceutica en forma de liberacion lenta y que comprende pinacidil (n'-ciano-n-4-piridil-n'-1, 2, 2-trimetil-propilguanidina), opcionalmente junto con otros componentes Expired ES8608490A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK0589/83A DK58983D0 (da) 1983-02-11 1983-02-11 Farmaceutisk praeparat

Publications (2)

Publication Number Publication Date
ES8608490A1 true ES8608490A1 (es) 1986-06-16
ES529660A0 ES529660A0 (es) 1986-06-16

Family

ID=8095276

Family Applications (1)

Application Number Title Priority Date Filing Date
ES529660A Expired ES8608490A1 (es) 1983-02-11 1984-02-10 Procedimiento de obtencion de una preparacion farmaceutica en forma de liberacion lenta y que comprende pinacidil (n'-ciano-n-4-piridil-n'-1, 2, 2-trimetil-propilguanidina), opcionalmente junto con otros componentes

Country Status (15)

Country Link
US (1) US4600577A (OSRAM)
JP (1) JPS59155312A (OSRAM)
BE (1) BE898882A (OSRAM)
DE (1) DE3404595A1 (OSRAM)
DK (1) DK58983D0 (OSRAM)
ES (1) ES8608490A1 (OSRAM)
FR (1) FR2540727B1 (OSRAM)
GB (1) GB2134785B (OSRAM)
IE (1) IE56604B1 (OSRAM)
IT (1) IT1196682B (OSRAM)
NL (1) NL8400430A (OSRAM)
NZ (1) NZ207010A (OSRAM)
PH (1) PH21734A (OSRAM)
SE (1) SE447871B (OSRAM)
ZA (1) ZA84856B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
EP0302595B1 (en) * 1987-07-07 1994-02-02 Beecham Group Plc Pinacidil for treatment of pulmonary hypertension or right heart failure
US5009894A (en) * 1988-03-07 1991-04-23 Baker Cummins Pharmaceuticals, Inc. Arrangement for and method of administering a pharmaceutical preparation
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
EP1146862B1 (de) 1999-01-29 2003-04-23 Disphar International B.V. Pharmazeutische zusammensetzungen
US6210716B1 (en) * 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
WO2000067754A1 (en) * 1999-05-12 2000-11-16 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
JP5502254B2 (ja) * 2001-01-31 2014-05-28 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 少なくとも２種類の異なる被覆ペレット形から成る多粒子剤形
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
KR20170097787A (ko) 2007-10-12 2017-08-28 다케다 파마슈티칼스 유에스에이, 인코포레이티드 음식 섭취와 관계없이 위장 장애를 치료하는 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
JPS54129115A (en) * 1978-03-31 1979-10-06 Yasuyo Miyauchi Long acting amoxycilin preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
DE3127984A1 (de) * 1981-07-15 1983-02-03 Klinge Pharma GmbH, 8000 München Orale arzneimittel fuer die kariesprophylaxe

Also Published As

Publication number Publication date
FR2540727A1 (fr) 1984-08-17
FR2540727B1 (fr) 1987-01-23
PH21734A (en) 1988-02-10
SE8400723D0 (sv) 1984-02-10
NZ207010A (en) 1987-06-30
DE3404595A1 (de) 1984-08-16
GB2134785B (en) 1986-07-02
IT1196682B (it) 1988-11-25
JPH0451528B2 (OSRAM) 1992-08-19
DK58983D0 (da) 1983-02-11
IE56604B1 (en) 1991-10-09
NL8400430A (nl) 1984-09-03
US4600577A (en) 1986-07-15
IT8467131A0 (it) 1984-02-13
DE3404595C2 (OSRAM) 1993-04-29
SE447871B (sv) 1986-12-22
IE840146L (en) 1984-08-11
GB2134785A (en) 1984-08-22
BE898882A (fr) 1984-08-10
IT8467131A1 (it) 1985-08-13
GB8403572D0 (en) 1984-03-14
ES529660A0 (es) 1986-06-16
JPS59155312A (ja) 1984-09-04
SE8400723L (sv) 1984-08-12
ZA84856B (en) 1984-09-26

Similar Documents

Publication Publication Date Title
ES8608490A1 (es) Procedimiento de obtencion de una preparacion farmaceutica en forma de liberacion lenta y que comprende pinacidil (n'-ciano-n-4-piridil-n'-1, 2, 2-trimetil-propilguanidina), opcionalmente junto con otros componentes
IT1221012B (it) Polimeri caricati con farmaci con migliorate solubilita' e biodisponibilita',procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
NO863997D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
JPH0220606B2 (OSRAM)
FI882315L (fi) Viskositeettia modifioivia polymeereja ja menetelmä niiden valmistamiseksi
ES8602407A1 (es) Perfeccionamientos en los metodos de fabricacion del acido 3-cloro-7-d-(2-fenilglicinamido)-3-cefem-4-carboxilico monohidratado
DE3880762D1 (de) Orale, acetaminophen enthaltende zusammensetzung mit gesteuerter arzneistoff-freisetzung und verfahren zu ihrer herstellung.
NO175618C (no) Fremgangsmåte for fremstilling av en farmasöytisk formulering med kontrollert frigjöring for oral administrering omfattende atskilte enheter omfattende acrivastin eller et salt derav
PT80583B (pt) Processo para a preparacao de uma composicao farmaceutica em forma de dose unitaria de libertacao constante
ES521763A0 (es) Procedimiento para la preparacion de derivados de acido (2-nitro-5-ariloxi-fenilamino)-alquil-fosfonico,fosfinico y fosfonoso.
ES462418A1 (es) Un procedimiento para la preparacion de composiciones biolo-gicamente activas.
IT1180507B (it) Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
FI901290A7 (fi) Menetelmä vaikuttavaa ainetta portaittain vapauttavan transdermaalisen terapeuttisen järjestelmän valmistamiseksi ja sen käyttö vaikuttavan aineen paikalliseen tai systeemiseen antamiseen
IT8720389A0 (it) Esteri retinoici di antibiotici, loro procedimento di preparazione e composizioni farmaceutiche e cosmetiche che li contengono.
FI854178A7 (fi) 1,2,4-triatsolo-karbamaatti ja sen happoadditiosuolat, näiden valmistusmenetelmät ja lääkeaineet.
DE3065878D1 (en) Diphosphonic and triphosphonic acid esters, their preparation and applications
ES524582A0 (es) Procedimiento para la preparacion de nuevos derivados de acidos (di)-tiofosforicos y fosfonicos.
FR2544718B1 (fr) Diniflumate d'ester morpholinoethylique d'acide niflumique, preparation, utilisation en therapeutique comme analgesique et anti-inflammatoire
DK688888D0 (da) Substituerede 1,4-dihydro-4-oxoquinolin-3-carboxylsyrer, farmaceutisk acceptable estre eller salte deraf, deres fremstilling og anvendelse
EP0140203A3 (de) Pharmazeutische Zubereitung
FI881307A7 (fi) Menetelmä sydämeen ja kardiovaskulaariseen järjestelmään vaikuttavien farmaseuttisten koostumusten valmistamiseksi.
FI884225A7 (fi) Uusia aminohappoestereitä, menetelmiä niiden valmistamiseksi, niitä sisältäviä lääkeaineita ja niiden käyttö.
FI813845A7 (fi) N-pyrimidinyyli-karbamiini- happoestereitä, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita.
IT1206144B (it) N-ossidi di esteri di acido piridilcarbossilico, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
IT1198263B (it) Esteri dell'azoniaspironortropanolo,procedimento per la loro preparazione,mezzi farmaceutici che li contengono e impiego di esteri dell'azoniaspironortropanolo come spasmolitico,asmaterapeutico e broncolitico